Bio Protocol vs CantonNetwork — how do they compare? Bio Protocol trades at Rp493.87 (market cap Rp1,11T, Rp291,14M 24h volume), while CantonNetwork trades at Rp2,391 (market cap Rp94,58T, Rp253,52M 24h volume). The key difference: CantonNetwork is far larger — about 85.2× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while CantonNetwork's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and CantonNetwork for 7 Days on average.
| BIO | CC | |
|---|---|---|
Market Cap | Rp1,11T | Rp94,58T |
Volume (24h) | Rp291,14M | Rp253,52M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 39,1B CC |
Typical Hold Time | 16 Days | 7 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
CantonNetwork (CC) is trading at Rp2,415.26 with a market cap of Rp94.16T, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token recently gained exposure through inclusion in Virtune's Stablecoin Index ETP and Bitget Launchpool listing, providing new liquidity channels. Current price sits between key support at Rp2,359 and resistance at Rp2,481, with RSI levels suggesting potential oversold conditions.
Overall outlook remains cautious due to bearish technical momentum, though recent exchange listings and institutional product inclusions offer growth opportunities. Major risks include typical crypto volatility, regulatory uncertainty, and dependence on Canton Network's adoption. Investors should monitor network activity and trading volume patterns for directional cues.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Canton Network is a layer-1 blockchain for RWAs and TradFi, offering smart contracts with configurable privacy. Its two-tier consensus supports scalable, interoperable apps. Canton Coin (CC) is used to pay network fees and reward participants.
Read more on CC →